Biggest News Aggregation in the World
๐Ÿ“ฐ Ioscience News

Page 25 - Ioscience News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ioscience. Real-time updates on events, politics, business and more.

InFlectis BioScience Receives Approval from French Regulatory Authority to Conduct a Phase 2 Clinical Trial for IFB-088 (Icerguastat) for the Treatment of Amyotrophic Lateral Sclerosis

InFlectis BioScience Receives Approval from French Regulatory Authority to Conduct a Phase 2 Clinical Trial for IFB-088 (Icerguastat) for the Treatment of
Pierre Miniou Francina Agosti Philippe Guedat Reportable Inc French Regulatory Authority Inflectis Bioscience

Lexaria Bioscience Corp.: Lexaria Receives Independent Review Board Approval For DehydraTECH-CBD Human Clinical Study HYPER-H21-4

โ€ข Dosing is expected to begin by April, 2022KELOWNA, BC / ACCESSWIRE / December 29, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug
George Jurcic Exchange Commission Company Or Lexaria Lexaria Bioscience Corp Drug Administration Lexaria Bioscience

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science